Skip to main content

Breast Cancer Research and Treatment

Ausgabe 2/2015

Inhalt (27 Artikel)

Review

A framework for the role of acute inflammation in tumor progression

Gabriela Szalayova, Ted A. James, Mercedes Rincon

Review

Predictive factors of nipple involvement in breast cancer: a systematic review and meta-analysis

Hanwen Zhang, Yaming Li, Meena S. Moran, Bruce G. Haffty, Qifeng Yang

Review

Adjuvant dose-dense chemotherapy in breast cancer: a systematic review and meta-analysis of randomized trials

Fausto Petrelli, Mary Cabiddu, Andrea Coinu, Karen Borgonovo, Mara Ghilardi, Veronica Lonati, Sandro Barni

Review

Incidental primary breast cancer detected on PET–CT

A. P. Benveniste, E. M. Marom, M. F. Benveniste, O. Mawlawi, P. S. Fox, Wei Yang

Preclinical Study

Targeting breast cancer stem cells in triple-negative breast cancer using a combination of LBH589 and salinomycin

Masaya Kai, Noriko Kanaya, Shang V. Wu, Carlos Mendez, Duc Nguyen, Thehang Luu, Shiuan Chen

Preclinical study

Genome-wide analysis of alternative transcripts in human breast cancer

Ji Wen, Kevin H. Toomer, Zhibin Chen, Xiaodong Cai

Preclinical study

Progesterone receptor A predominance is a discriminator of benefit from endocrine therapy in the ATAC trial

Patricia A. Mote, Anne Gompel, Chris Howe, Heidi N. Hilton, Ivana Sestak, Jack Cuzick, Mitch Dowsett, Danielle Hugol, Patricia Forgez, Karen Byth, J. Dinny Graham, Christine L. Clarke

Preclinical study

Exome sequencing of contralateral breast cancer identifies metastatic disease

Daniel Klevebring, Johan Lindberg, Julia Rockberg, Camilla Hilliges, Per Hall, Maria Sandberg, Kamila Czene

Preclinical study

Markers of progression in early-stage invasive breast cancer: a predictive immunohistochemical panel algorithm for distant recurrence risk stratification

Mohammed A. Aleskandarany, D. Soria, A. R. Green, C. Nolan, Maria Diez-Rodriguez, I. O. Ellis, E. A. Rakha

Preclinical study

AroER tri-screen™ is a novel functional assay to estimate both estrogenic and estrogen precursor activity of chemicals or biological specimens

Noriko Kanaya, Duc M. Nguyen, Hannah Lu, Yuan-Zhong Wang, Li-Yu Hsin, Myrto Petreas, David Nelson, Weihong Guo, Peggy Reynolds, Tim Synold, Shiuan Chen

Clinical trial

Moderate level of HER2 expression and its prognostic significance in breast cancer with intermediate grade

Tanja Ignatov, Holm Eggemann, Elke Burger, Franziska Fettke, Serban Dan Costa, Atanas Ignatov

Clinical Trial

Incidental radiation to uninvolved internal mammary lymph nodes in breast cancer

Divya Arora, Jessica Frakes, Jacob Scott, Daniel Opp, Carol Johnson, Juhee Song, Eleanor Harris

Clinical Trial

CYP19A1 polymorphisms and clinical outcomes in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1–98 trial

Brian Leyland-Jones, Kathryn P. Gray, Mark Abramovitz, Mark Bouzyk, Brandon Young, Bradley Long, Roswitha Kammler, Patrizia Dell’Orto, Maria Olivia Biasi, Beat Thürlimann, Maria B. Lyng, Henrik J. Ditzel, Vernon J. Harvey, Patrick Neven, Isabelle Treilleux, Birgitte Bruun Rasmussen, Rudolf Maibach, Karen N. Price, Alan S. Coates, Aron Goldhirsch, Olivia Pagani, Giuseppe Viale, James M. Rae, Meredith M. Regan

Open Access Clinical trial

Impact of adjuvant taxane-based chemotherapy on development of breast cancer-related lymphedema: results from a large prospective cohort

Meyha N. Swaroop, Chantal M. Ferguson, Nora K. Horick, Melissa N. Skolny, Cynthia L. Miller, Lauren S. Jammallo, Cheryl L. Brunelle, Jean A. O’Toole, Steven J. Isakoff, Michelle C. Specht, Alphonse G. Taghian

Clinical Trial

Relative dose intensity and therapy efficacy in different breast cancer molecular subtypes: a retrospective study of early stage breast cancer patients treated with neoadjuvant chemotherapy

Jia-qi Yuan, Shou-man Wang, Li–li Tang, Jie Mao, Yu-hui Wu, Jian Hai, Sha-yang Luo, Hui-ying Ou, Lei Guo, Li-qiu Liao, Jun Huang, Yan Li, Zhi Xiao, Ke-jing Zhang, Na Luo, Fei-yu Chen

Epidemiology

Premenopausal plasma carotenoids, fluorescent oxidation products, and subsequent breast cancer risk in the nurses’ health studies

Julia S. Sisti, Sara Lindström, Peter Kraft, Rulla M. Tamimi, Bernard A. Rosner, Tianying Wu, Walter C. Willett, A. Heather Eliassen

Epidemiology

Validation of self-reported post-treatment mammography surveillance among breast cancer survivors by electronic medical record extraction method

Jasmin A. Tiro, Joanne M. Sanders, L. Aubree Shay, Caitlin C. Murphy, Heidi A. Hamann, L. Kay Bartholomew, Lara S. Savas, Sally W. Vernon

Epidemiology

Prospective evaluation of alcohol consumption and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers

Cezary Cybulski, Jan Lubinski, Tomasz Huzarski, Henry T. Lynch, Susan Armel Randall, Susan L. Neuhausen, Leigha Senter, Susan Friedman, Peter Ainsworth, Christian Singer, William D. Foulkes, Steven A. Narod, Ping Sun, Joanne Kotsopoulos

Epidemiology

Invasive micropapillary mucinous carcinoma of the breast is associated with poor prognosis

Fangfang Liu, Mu Yang, Zhenhua Li, Xiaojing Guo, Yang Lin, Ronggang Lang, Beibei Shen, Gordon Pringle, Xinmin Zhang, Li Fu

Epidemiology

Body mass index associated with genome-wide methylation in breast tissue

Brionna Y. Hair, Zongli Xu, Erin L. Kirk, Sophia Harlid, Rupninder Sandhu, Whitney R. Robinson, Michael C. Wu, Andrew F. Olshan, Kathleen Conway, Jack A. Taylor, Melissa A. Troester

Epidemiology

Comparison of breast cancer risk in women with and without systemic lupus erythematosus in a Medicare population

Waseem Khaliq, Rehan Qayyum, Jeffrey Clough, Dhananjay Vaidya, Antonio C. Wolff, Diane M. Becker

Letter to the Editor

Interpretation of genomic variation and disease association: the great missense mutation challenge!

Tú Nguyen-Dumont, Ingrid Winship, Melissa C. Southey

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.